Cargando…
国产与原研伊马替尼治疗初诊慢性期慢性髓性白血病的疗效和安全性比较——多中心回顾性临床研究
OBJECTIVE: To evaluate the efficacy and safety of generic imatinib (Genike, Chiatai Tianqing Pharmaceutical Group Co., Ltd.) and imatinib (Glevic, Novartis, Switzerland) in newly diagnosed patients with chronic myeloid leukemia in chronic phase (CML-CP). METHODS: A retrospective study of 323 CML-CP...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342286/ https://www.ncbi.nlm.nih.gov/pubmed/28810322 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.07.003 |